SETH KEATING: Open Payments
NPI 1023663614 · CLEVELAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 9 payments from 9 companies in 2025. Trend: 2023 $484 · 2024 $512 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
| Tris Pharma Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: CAPLYTA, INGREZZA, PREVNAR 20, Auvelity, TRELEGY ELLIPTA, NEFFY, Onyda XR, MOUNJARO.
Industry payments across TX — which companies pay providers there.
